Anika Therapeutics(ANIK) - 2024 Q2 - Quarterly Results

EXHIBIT 99.1 Anika Reports Second Quarter 2024 Financial Results Expanded Regenerative Solutions portfolio with full market release of the Integrity™ Implant System, a hyaluronic acid (HA)-based scaffold for rotator cuff and other tendon repairs, generating significant market demand Delivered revenue in line with expectations with 15% adjusted EBITDA margins; Strong first half 2024 international OA Pain Management revenue growth of 17% Enhanced capital allocation strategy with new $40 million share repurcha ...